BWAYNasdaqSurgical & Medical Instruments & ApparatusAlso trades as BRSYF
Brainsway Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 20, 2026
$11.99+0.55 (+4.81%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 66.6
- Dividend yield
- –
Brainsway Ltd. revenue by segment
By business segment
By product or service
By region
| Revenue | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Country Of U S A [Member] | $33.23M | $23.98M | $20.30M | $26.09M | – | – | 81.0% | +38.6% |
| Other [Member] | $7.79M | $7.81M | $6.88M | $3.56M | $730.00K | $845.00K | 19.0% | -0.2% |
| USA [Member] | – | – | $21.22M | $26.09M | $19.33M | $20.64M | – | – |
| Europes [Member] | – | – | $1.75M | $2.03M | $1.85M | $1.35M | – | – |
| Israel [Member] | – | – | – | $149.00K | $150.00K | $267.00K | – | – |
| A P A C [Member] | – | – | $4.19M | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Brainsway's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.